HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: T600020-MCP200v1 5/10/1996    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haab, B. B. Articles by Uhlen, M. Search for Related Content PubMed PubMed Citation Articles by Haab, B. B. Articles by Uhlen, M. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 5:1996-2007, 2006.
© 2006 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Meeting Report

A Reagent Resource to Identify Proteins and Peptides of Interest for the Cancer Community

A WORKSHOP REPORT^*

From the ^a Van Andel Research Institute, Grand Rapids, Michigan 49503, ^c Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, ^d Plasma Proteome Institute, Washington, D. C. 20009, ^f Office of Technology and Industrial Relations, NCI, National Institutes of Health, Bethesda, Maryland 20892, ^h European Molecular Biology Laboratory-European Bioinformatics Institute, Hinxton, Cambridge CB10 1SD, United Kingdom, ⁱ Harvard Institute of Proteomics, Harvard University, Cambridge, Massachusetts 02141-2023, and ^j Royal Institute of Technology, 106 91 Stockholm, Sweden

On the basis of discussions with representatives from all sectors of the cancer research community, the National Cancer Institute (NCI) recognizes the immense opportunities to apply proteomics technologies to further cancer research. Validated and well characterized affinity capture reagents (e.g. antibodies, aptamers, and affibodies) will play a key role in proteomics research platforms for the prevention, early detection, treatment, and monitoring of cancer. To discuss ways to develop new resources and optimize current opportunities in this area, the NCI convened the "Proteomic Technologies Reagents Resource Workshop" in Chicago, IL on December 12–13, 2005. The workshop brought together leading scientists in proteomics research to discuss model systems for evaluating and delivering resources for reagents to support MS and affinity capture platforms. Speakers discussed issues and identified action items related to an overall vision for and proposed models for a shared proteomics reagents resource, applications of affinity capture methods in cancer research, quality control and validation of affinity capture reagents, considerations for target selection, and construction of a reagents database. The meeting also featured presentations and discussion from leading private sector investigators on state-of-the-art technologies and capabilities to meet the user community’s needs. This workshop was developed as a component of the NCI’s Clinical Proteomics Technologies Initiative for Cancer, a coordinated initiative that includes the establishment of reagent resources for the scientific community. This workshop report explores various approaches to develop a framework that will most effectively fulfill the needs of the NCI and the cancer research community.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. E. Gloriam, S. Orchard, D. Bertinetti, E. Bjorling, E. Bongcam-Rudloff, C. A. K. Borrebaeck, J. Bourbeillon, A. R. M. Bradbury, A. de Daruvar, S. Dubel, et al. A Community Standard Format for the Representation of Protein Affinity Reagents Mol. Cell. Proteomics, January 1, 2010; 9(1): 1 - 10. [Abstract] [Full Text] [PDF]

				O. Vielemeyer, H. Yuan, S. Moutel, R. Saint-Fort, D. Tang, C. Nizak, B. Goud, Y. Wang, and F. Perez Direct Selection of Monoclonal Phosphospecific Antibodies without Prior Phosphoamino Acid Mapping J. Biol. Chem., July 31, 2009; 284(31): 20791 - 20795. [Abstract] [Full Text] [PDF]

				S. Mathivanan and A. Pandey Human Proteinpedia as a Resource for Clinical Proteomics Mol. Cell. Proteomics, October 1, 2008; 7(10): 2038 - 2047. [Abstract] [Full Text] [PDF]

				E. Bjorling and M. Uhlen Antibodypedia, a Portal for Sharing Antibody and Antigen Validation Data Mol. Cell. Proteomics, October 1, 2008; 7(10): 2028 - 2037. [Abstract] [Full Text] [PDF]

				L. Berglund, E. Bjorling, P. Oksvold, L. Fagerberg, A. Asplund, C. Al-Khalili Szigyarto, A. Persson, J. Ottosson, H. Wernerus, P. Nilsson, et al. A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies Mol. Cell. Proteomics, October 1, 2008; 7(10): 2019 - 2027. [Abstract] [Full Text] [PDF]

				J. Huang, A. Koide, K. Makabe, and S. Koide Design of protein function leaps by directed domain interface evolution PNAS, May 6, 2008; 105(18): 6578 - 6583. [Abstract] [Full Text] [PDF]

				E. Bjorling, C. Lindskog, P. Oksvold, J. Linne, C. Kampf, S. Hober, M. Uhlen, and F. Ponten A Web-based Tool for in Silico Biomarker Discovery Based on Tissue-specific Protein Profiles in Normal and Cancer Tissues Mol. Cell. Proteomics, May 1, 2008; 7(5): 825 - 844. [Abstract] [Full Text] [PDF]

				M. Uhlen Mapping the Human Proteome Using Antibodies Mol. Cell. Proteomics, August 1, 2007; 6(8): 1455 - 1456. [Full Text] [PDF]